HK Stock MarketDetailed Quotes

01875 TOT BIOPHARM-B

Watchlist
  • 1.900
  • 0.0000.00%
Trading May 8 09:43 CST
1.47BMarket Cap38.78P/E (TTM)

TOT BIOPHARM-B Key Stats

TOT BIOPHARM-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.615B--
--2025/FY-- / 1.378B--
Mar 11, 20252024/FY1.098B / 1.095B--
Mar 24, 20222021/FY76.325M / 51.900M--
Mar 23, 20212020/FY22.491M / 53.213M--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.615B--
--2025/FY-- / 1.378B--
Mar 11, 20252024/FY1.098B / 1.095B--
Mar 24, 20222021/FY76.325M / 51.900M--
Mar 23, 20212020/FY22.491M / 53.213M--

Unlock Free Earnings Estimates

TOT BIOPHARM-B Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More